An evaluation of high-dose vitamin D for rheumatoid arthritis

J Clin Rheumatol. 2014 Mar;20(2):112-4. doi: 10.1097/RHU.0000000000000072.

Authors

Karen E Hansen¹, Christie M Bartels, Ronald E Gangnon, Andrea N Jones, Jyothi Gogineni

Affiliation

¹ From the *Department of Medicine, School of Medicine & Public Health, and †Departments of Biostatistics and Medical Informatics & Population Health Sciences, University of Wisconsin, Madison, WI; and ‡Centegra Health System, Crystal Lake, IL.

No abstract available

Publication types

Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Arthritis, Rheumatoid / blood
Arthritis, Rheumatoid / drug therapy*
Bone Density / drug effects
Cytokines / blood
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Male
Middle Aged
Parathyroid Hormone / blood
Severity of Illness Index
Treatment Outcome
Vitamin D / pharmacology
Vitamin D / therapeutic use*

Substances

Cytokines
Parathyroid Hormone
Vitamin D

Grants and funding